1 – 20 of 36
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases : A nationwide multicenter study with short- and long-term follow-up
(
- Contribution to journal › Article
-
Mark
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior
(
- Contribution to journal › Article
-
Mark
Some epidemiological aspects of liver cirrhosis and hepatocellular carcinoma in Sweden
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma : A nationwide cohort study of 3473 patients
(
- Contribution to journal › Article
-
Mark
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
(
- Contribution to journal › Article
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
(
- Contribution to journal › Article
-
Mark
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
Metabolic perturbations prior to hepatocellular carcinoma diagnosis : Findings from a prospective observational cohort study
(
- Contribution to journal › Article
- 2019
-
Mark
Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study
(
- Contribution to journal › Article
-
Mark
Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults
(
- Contribution to journal › Article
-
Mark
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden : a population-based study
(
- Contribution to journal › Article
- 2017
-
Mark
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma : A nested case-control study
(
- Contribution to journal › Article
- 2016
-
Mark
Cylindromatosis-A Protective Molecule against Liver Diseases.
(
- Contribution to journal › Scientific review
-
Mark
BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin
(
- Contribution to journal › Article
-
Mark
Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients
(
- Contribution to journal › Article
-
Mark
Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study
(
- Contribution to journal › Article
-
Mark
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
(
- Contribution to journal › Article
- 2014
-
Mark
Dairy products and risk of hepatocellular carcinoma: The European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article